🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John F. Deeken

Inova Health System

ORCID: 0000-0001-8414-1553

Also affiliated with Inova Fairfax Hospital, Virginia Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.271Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618
Top 58%
0.271DataRank
Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Papers

Driven by 5 papers — median percentile 21. Top paper: “A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance”.

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022
N/A
0.529DataRank · unranked
33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study

The Oncologist(2022)10.1093/oncolo/oyac004
N/A
0.317DataRank · unranked
5 citations

Page C. Moore, Milan Bimali, Timothy P. Cooley, Joseph A. Sparano, Michelle A. Rudek +7 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618
Top 58%
0.271DataRank
Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

A phase I trial of the mTOR inhibitor temsirolimus (TEM) in combination with capecitabine (CAP) in patients with advanced malignancies.

Journal of Clinical Oncology(2012)10.1200/jco.2012.30.15_suppl.3095
N/A
0.104DataRank · unranked
1 citations

Hongkun Wang, Rosemarie A. Hardesty, John F. Deeken, Aiwu Ruth He, Deepa Suresh Subramaniam +7 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038
Top 100%
0DataRank
Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more